Evoke Pharma EVOK reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Evoke Pharma missed estimated earnings by 18.33%, reporting an EPS of $-0.71 versus an estimate of $-0.6.
Revenue was up $225 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.36 which was followed by a 21.74% drop in the share price the next day.
Here's a look at Evoke Pharma's past performance:
Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
---|---|---|---|---|
EPS Estimate | -0.48 | -0.96 | -0.84 | -0.96 |
EPS Actual | -0.84 | -0.72 | -0.72 | -0.84 |
Revenue Estimate | 530K | 510K | 380K | 150K |
Revenue Actual | 418K | 360K | 930K | 236K |
To track all earnings releases for Evoke Pharma visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.